Yokohama, Japan

Itsuo Uchida

This inventor holds 12 USPTO granted patents. Top assignees: Japan Tobacco Inc., Yoshitomi Pharmaceutical Industries, Ltd.. Active years: 1992-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Itsuo Uchida. Retrieved from https://idiyas.com/inventor/itsuo-uchida-1ns92dpx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.7

ph-index = 8

Forward Citations = 120(Granted Patents)


Location History:

  • Yokohama, JP (1992 - 1994)
  • Kanagawa, JP (1994)
  • Takatsuki, JP (1996 - 1998)

Company Filing History:


Years Active: 1992-1998

Loading Chart...
12 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Itsuo Uchida

Introduction

Itsuo Uchida is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with therapeutic applications. With a total of 12 patents to his name, Uchida's work has had a considerable impact on medical science.

Latest Patents

Among his latest patents are innovative compounds such as a dioxacycloalkane compound having renin-inhibitory activity and a chroman derivative with pharmaceutical uses. These inventions highlight his focus on creating effective treatments for various health conditions.

Career Highlights

Uchida has worked with prominent companies in the pharmaceutical industry, including Japan Tobacco Inc. and Yoshitomi Pharmaceutical Industries, Ltd. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research.

Collaborations

Throughout his career, Uchida has collaborated with esteemed colleagues such as Koji Kobayashi and Kunio Iwata. These partnerships have fostered a collaborative environment that has led to innovative solutions in the pharmaceutical sector.

Conclusion

Itsuo Uchida's contributions to the field of pharmaceuticals through his patents and collaborations demonstrate his commitment to advancing medical science. His work continues to influence the development of new therapeutic compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…